MetaADEDB 2.0 @ LMMD
binedaline
(SXYFFMXPDDGOEK-UHFFFAOYSA-N)
Structure
SMILES
CN(CCN(n1cc(c2c1cccc2)c1ccccc1)C)C
Molecular Formula:
C19H23N3
Molecular Weight:
293.406
Log P:
3.4377
Hydrogen Bond Acceptor:
3
Hydrogen Bond Donor:
0
TPSA:
11.41
CAS Number(s):
60662-16-0
Synonym(s)
1.
binedaline
2.
Sgd Scha 1059
3.
binedaline monohydrochloride
4.
binodaline
External Link(s)
MeSHC044680
PubChem Compound42510
CHEMBLCHEMBL2104611
ZINC1032
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abnormal visionOFFSIDES
2AcidosisOFFSIDES
3Acquired Protein S DeficiencyOFFSIDES
4AgraphiaOFFSIDES
5Alopecia totalisOFFSIDES
6AmimiaOFFSIDES
7Amnestic DisorderOFFSIDES
8AngioedemaOFFSIDES
9Angle Closure GlaucomaOFFSIDES
10AnorexiaOFFSIDES
11Antibiotic level above therapeuticOFFSIDES
12Anticholinergic SyndromeOFFSIDES
13ApathyOFFSIDES
14Aphthous StomatitisOFFSIDES
15Arteriopathic diseaseOFFSIDES
16AuraOFFSIDES
17Axonal neuropathyOFFSIDES
18Blood chloride decreasedOFFSIDES
19Blood creatine increasedOFFSIDES
20Blood fibrinogenOFFSIDES
21Blood glucose decreasedOFFSIDES
22Blood immunoglobulin A increasedOFFSIDES
23Blood sodiumOFFSIDES
24Bronchoalveolar LavageOFFSIDES
25Burning Mouth SyndromeOFFSIDES
26C-reactive protein abnormalOFFSIDES
27Central nervous system lesionOFFSIDES
28Cerebral ataxiaOFFSIDES
29CholangiolitisOFFSIDES
30Compulsive shoppingOFFSIDES
31ConfabulationOFFSIDES
32Conversion disorderOFFSIDES
33Corneal UlcerOFFSIDES
34Creatinine renal clearance decreasedOFFSIDES
35Cytolytic hepatitisOFFSIDES
36Decreased insulin requirementOFFSIDES
37Dopamine dysregulation syndromeOFFSIDES
38DrowsinessOFFSIDES
39GamblingOFFSIDES
40Gamma-Glutamyltransferase IncreasedOFFSIDES
41General physical health deteriorationOFFSIDES
42GlobulinuriaOFFSIDES
43Hallucinations, mixedOFFSIDES
44Hepatitis B positiveOFFSIDES
45HepatitisOFFSIDES
46HepatosplenomegalyOFFSIDES
47HyporeflexiaOFFSIDES
48LeukoencephalopathyOFFSIDES
49Leukopenia neonatalOFFSIDES
50LymphangitisOFFSIDES
51MonoplegiaOFFSIDES
52Motor retardationOFFSIDES
53Multiple SclerosisOFFSIDES
54MutismOFFSIDES
55Nephrotic SyndromeOFFSIDES
56PallorOFFSIDES
57Portal HypertensionOFFSIDES
58Prothrombin level decreasedOFFSIDES
59Prothrombin time ratio decreasedOFFSIDES
60PyelonephritisOFFSIDES
61RalesOFFSIDES
62Renal tubular disorderOFFSIDES
63Sense of oppressionOFFSIDES
64Septic ShockOFFSIDES
65SigmoiditisOFFSIDES
66Skin graft failureOFFSIDES
67Soft Tissue InfectionOFFSIDES
68Stevens-Johnson SyndromeOFFSIDES
69TenosynovitisOFFSIDES
70Transaminases increasedOFFSIDES
71Troponin increasedOFFSIDES
72Venous InsufficiencyOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.